Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MDL 19301 is a nonsteroidal, anti-inflammatory agent.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | Inquiry | $ 1,520.00 |
Description | MDL 19301 is a nonsteroidal, anti-inflammatory agent. |
In vivo | MDL 19301 exhibits additional anti-inflammatory effects by inhibiting carrageenan pleurisy, adjuvant arthritis, and HOAc-induced writhing. Pharmacologically, it suppresses prostaglandin synthesis, blocks arachidonic acid-induced diarrhea (excluding prostaglandin-E2-caused), and prevents arachidonic-acid-stimulated rat platelet aggregation (excluding ADP-induced). Contrary to expectations, both MDL 19301 and MDL 16,861 show minimal antipyretic effects in rats. Remarkably, oral MDL 19301 administration reduces rat paw edema significantly, induced either by carrageenan (ED30=4.8 mg/kg) or an Arthus reaction (ED30=8.2 mg/kg p.o.), and does not cause gastric ulceration in fasted rats at doses up to 1,000 mg/kg, indicating a better therapeutic index than traditional non-steroidal anti-inflammatory drugs (NSAIDs). The anti-inflammatory effect of MDL 19301 (unlike MDL 16,861) diminishes with SKF525A co-administration, suggesting MDL 19301's prodrug status for MDL 16,861 and its lower ulcerogenic potential. |
Molecular Weight | 279.46 |
Formula | C15H21NS2 |
CAS No. | 89388-38-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
MDL 19301 89388-38-5 Others MDL19301 MDL-19301 inhibitor inhibit